CRSP: CRISPR Therapeutics Corp Sotuvga nisbatan narx

CRISPR Therapeutics Inc (CRSP) kompaniyasining korporativ logotipi

CRISPR Therapeutics AG (CRSP) biomateriallarning barqaror yetkazib berilishi uchun hamkor laboratoriyalar tarmog'iga tayanadi. Samartit Chatterjee boshlig'idagi tajribali rahbariyat ilk gen terapiyasini muvaffaqiyatli tijoratlashtirdi. Jori P/S koeffitsienti ushbu yutuqlarni aks ettiradi va ushbu ko'rsatkich 155.70 darajasida qat'iy belgilangan. Bu dori vositalari xususiyatlarining mutlaq saqlanishini kafolatlovchi kriogen logistikaning yuqori qiymatini tasdiqlaydi.

CRSP: CRISPR Therapeutics AG P/S multiplikatori 04.07.2022 - 17.11.2026

CRISPR Therapeutics Inc (CRSP) kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahliliyoti:CRSP CRISPR Therapeutics Corp
CRISPR Therapeutics yetakchi tovari

CRISPR Therapeutics AG (CRSP) kompaniyasining global klinik sinovlari geosiyosiy xavflar va logistik uzilishlar ta'siriga duch kelmoqda, bu esa texnologiyaning tijoratlashtirish sur'atiga bevosita ta'sir qiladi. Kompaniyaning joriy P/S koeffitsiyentini tahlil qilish orqali investor biznesning bozor qiymatini uning haqiqiy savdo hajmi bilan nisbatda baholaydi, kelajakdagi o'sish uchun to'langan premiumni aniqlaydi va aktivni daromadlardagi o'zgarishlar natijasida qayta baholanish potentsialiga ega bo'lgan yuqori xavfli instrument sifatida baholaydi.

CRISPR Therapeutics AG kimlar bilan raqobatlashadi

TEM (Tempus AI, Inc.) - Bozor kapitallashuvining daromadga nisbati|Qiagen Group - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati IONS|RGEN - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Avidity Biosciences RNA|Sema4 (WGS) - Narxning daromadga nisbati|Narxning sotuvga nisbati RARE (Ultragenyx)|Kapitalizatsiyaning daromadga nisbati BEAM|P/S multiplikatori Sarepta Corp|Narxning daromadga nisbati Twist Bioscience, Inc. (TWST)|Kapitalizatsiyaning daromadga nisbati 10x Genomics TXG|Narxning daromadga nisbati Intellia Therapeutics NTLA|Kapitalizatsiyaning sotish hajmiga nisbati STOK (Stoke Therapeutics, Inc.)|BLFS - Narxning daromadga nisbati|Sotuvga nisbatan narx Wave Pharma|mazetx.com (MAZE) - Narxning daromadga nisbati|SION - Narx/daromad koeffitsiyenti|PRME (Prime Medicine Inc) - P/S multiplikatori|Taysha Gene Therapies, Inc. - Narxning sotuvga nisbati|P/S multiplikatori QURE|MGTX: Narxning sotuvga nisbati|Narxning daromadga nisbati REGENXBIO RGNX|SLDB: Kapitalizatsiya va daromad nisbati|OCGN: Kapitalizatsiyaning daromadga nisbati|PACB - P/S multiplikatori|BNTC (Benitec Corp) - Kapitalizatsiyaning daromadga nisbati|Narx/daromad multiplikatori Design Corp DSGN|Narxning daromadga nisbati Rocket Pharmaceuticals|P/S multiplikatori 4D Molecular Therapeutics, Inc.|Narxning daromadga nisbati Lexeo (LXEO)|KRRO (Korro Bio Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EDIT (Editas Medicine, Inc.)|P/S multiplikatori Silence Therapeutics Corp SLN|PRQR - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Codexis Inc CDXS|SGMO: P/S multiplikatori|Kapitalizatsiya va daromad nisbati NAUT|Narxning daromadga nisbati metagenomi.co|P/S multiplikatori Precision BioSciences Inc.|P/S multiplikatori GBIO|Boundless Bio, Inc. - Kapitalizatsiya va daromad nisbati|P/S multiplikatori XCUR (Exicure, Inc.)|Narx/daromad koeffitsiyenti Imunon, Inc. (IMNN)|PHIO - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati MBIO (mustangbio.com)|RNAZ: P/S multiplikatori|Kapitalizatsiya va daromad nisbati BNGO|APDN (Applied DNA Corp) - P/S multiplikatori|BLUE: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati ImmunoPrecise (IPA)|OMGA - Sotuvga nisbatan narx|Narxning daromadga nisbati Singular Genomics OMIC|Bozor kapitallashuvining daromadga nisbati RGLS|Syros Pharmaceuticals, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Telesis Bio Inc. TBIO|TRACON Pharmaceuticals, Inc. (TCON) - Narxning daromadga nisbati|Unity Biotechnology, Inc - Bozor kapitallashuvining daromadga nisbati